-
-
-
-
-
-
-
Johnson & Johnson MedTech (JNJ) Acquires Laminar, Inc. for $400 Million Plus Milestone Payments
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) Reports H1'23 Revenue of $42.41B, EPS $4.97; Updates Guidance on Completion of the Kenvue Separation
-
-
-
-
-
-
-
Alvotech (ALVO) and Teva (TEVA) Secure U.S. Settlement and License Deal with Johnson & Johnson (JNJ) for AVT04
-
-
-
-
-
-
-
Amgen (AMGN) acquires Horizon (HZNP) for $26 billion as Sanofi (SNY) drops bid
-
-
-
-
-
-
-
Today's Most Important Downgrades
-
-
-
-
-
-
-
Johnson & Johnson to Acquire Abiomed
-
-
-
-
-
-
-
Judge greenlights J&J strategy to resolve talc lawsuits in bankruptcy court
-
887,182 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All